OBJECTIVE: To define central venous catheter-related infections in infants and children for the purpose of enrolling children in sepsis studies, for epidemiology and surveillance studies, and for clinical management. METHODS: Review of the literature and consensus of experts. RESULTS: No changes were made to the current Centers for Disease Control and Prevention criteria for defining local catheter infection. Because catheter tips are not available as often in children as in adults, smaller blood volumes are drawn per culture decreasing sensitivity, and antibiotics are rarely withheld, slight modifications to the existing adult Centers for Disease Control and Prevention criteria were made to increase practical use. Catheter-related bloodstream infection was categorized as definite, probable, and possible based on culture results and clinical symptoms. CONCLUSIONS: For the purposes of enrolling patients with sepsis in clinical trials, only patients who meet criteria for definite catheter-related bloodstream infection should be categorized as having the catheter as the infection source. Because many patients suspected of having catheter-related bloodstream infection do not have positive blood culture results, which makes the confirmation of infection difficult, we recommend that these patients not be enrolled in sepsis trials. Because catheter tips are often not obtained for culture in children, the epidemiology of catheter-associated bloodstream infection (bloodstream infection in a patient who has a central venous catheter and no other obvious source of infection) is better understood than the epidemiology of confirmed catheter-related bloodstream infection in infants and children. Definitions for catheter-related bloodstream infection that compare the through-catheter and peripheral culture for time to positivity or for quantitative growth are unlikely to be falsely positive, but sensitivity requires further validation.
OBJECTIVE: To define central venous catheter-related infections in infants and children for the purpose of enrolling children in sepsis studies, for epidemiology and surveillance studies, and for clinical management. METHODS: Review of the literature and consensus of experts. RESULTS: No changes were made to the current Centers for Disease Control and Prevention criteria for defining local catheter infection. Because catheter tips are not available as often in children as in adults, smaller blood volumes are drawn per culture decreasing sensitivity, and antibiotics are rarely withheld, slight modifications to the existing adult Centers for Disease Control and Prevention criteria were made to increase practical use. Catheter-related bloodstream infection was categorized as definite, probable, and possible based on culture results and clinical symptoms. CONCLUSIONS: For the purposes of enrolling patients with sepsis in clinical trials, only patients who meet criteria for definite catheter-related bloodstream infection should be categorized as having the catheter as the infection source. Because many patients suspected of having catheter-related bloodstream infection do not have positive blood culture results, which makes the confirmation of infection difficult, we recommend that these patients not be enrolled in sepsis trials. Because catheter tips are often not obtained for culture in children, the epidemiology of catheter-associated bloodstream infection (bloodstream infection in a patient who has a central venous catheter and no other obvious source of infection) is better understood than the epidemiology of confirmed catheter-related bloodstream infection in infants and children. Definitions for catheter-related bloodstream infection that compare the through-catheter and peripheral culture for time to positivity or for quantitative growth are unlikely to be falsely positive, but sensitivity requires further validation.
Authors: M Angeles García-Teresa; Juan Casado-Flores; M Angel Delgado Domínguez; Jorge Roqueta-Mas; Francisco Cambra-Lasaosa; Andrés Concha-Torre; Cristina Fernández-Pérez Journal: Intensive Care Med Date: 2007-01-19 Impact factor: 17.440
Authors: Jacqueline Halton; Kim Nagel; Leonardo R Brandão; Mariana Silva; Paul Gibson; Anthony Chan; Kay Blyth; Kim Hicks; Nagina Parmar; Leslie Paddock; Stephanie Willing; Lehana Thabane; Uma Athale Journal: BMC Cancer Date: 2012-07-26 Impact factor: 4.430
Authors: Camila Marconi; Maria de Lourdes Rs Cunha; João C Lyra; Maria R Bentlin; Jackson En Batalha; Maria Fátima Sugizaki; Lígia Mss Rugolo Journal: Braz J Microbiol Date: 2008-06-01 Impact factor: 2.476